In inflammatory breast cancer (IBC), including TNBC, stromal TILs are associated with increased PD‐L1 and improved clinical outcome [37]; here, the co‐localisation of CD163+ myeloid cells (macrophages and/or DCs), not absolute numbers, was associated with achieving a pathological complete response [37]. The gene discussed is CD163; the disease is inflammatory breast carcinoma.